Aromatase Inhibitor News and Research

RSS
Aromatase Inhibitors are drugs that prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy for postmenopausal women who have hormone-dependent breast cancer.
Physicians discuss use of new guidelines on aromatase inhibitor to prevent breast cancer

Physicians discuss use of new guidelines on aromatase inhibitor to prevent breast cancer

Biomarker indicates which women are at risk for breast cancer recurrence after tamoxifen

Biomarker indicates which women are at risk for breast cancer recurrence after tamoxifen

Gabriel Hortobagyi recognized with AACR-MICR Jane Cooke Wright Lectureship

Gabriel Hortobagyi recognized with AACR-MICR Jane Cooke Wright Lectureship

New study shows some women don't stick to recommended treatment for breast cancer

New study shows some women don't stick to recommended treatment for breast cancer

Genetic differences in enzyme CYP2D6 play a key role in effectiveness of tamoxifen for breast cancer

Genetic differences in enzyme CYP2D6 play a key role in effectiveness of tamoxifen for breast cancer

ATLAS holds up 10-year tamoxifen regime

ATLAS holds up 10-year tamoxifen regime

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

Novartis to highlight key data from extensive oncology portfolio at SABCS and ASH meeting

ProStrakan acquires US commercial rights to Fareston for treatment of metastatic breast cancer

ProStrakan acquires US commercial rights to Fareston for treatment of metastatic breast cancer

Combination therapy delays progression for metastatic breast cancer patients

Combination therapy delays progression for metastatic breast cancer patients

Combination of anastrozole and fulvestrant extends survival in women with metastatic breast cancer

Combination of anastrozole and fulvestrant extends survival in women with metastatic breast cancer

Distinct cancer 'signatures' may help predict response to estrogen-lowering therapy

Distinct cancer 'signatures' may help predict response to estrogen-lowering therapy

New analysis may help identify breast cancer patients who will benefit from immune suppressant

New analysis may help identify breast cancer patients who will benefit from immune suppressant

Scientists use DNA sequencing to identify 'driver' mutations in cancer

Scientists use DNA sequencing to identify 'driver' mutations in cancer

Treatment with aromatase inhibitors enables some women to have lumpectomy

Treatment with aromatase inhibitors enables some women to have lumpectomy

Red wine could play a role in lowering risk of breast cancer

Red wine could play a role in lowering risk of breast cancer

Side effects and non-compliance with breast cancer therapy

Side effects and non-compliance with breast cancer therapy

Breast cancer hope with new drug and new combination regimens

Breast cancer hope with new drug and new combination regimens

Zoledronic acid increases bone mineral density, reduces recurrence in postmenopausal breast cancer

Zoledronic acid increases bone mineral density, reduces recurrence in postmenopausal breast cancer

Omega-3 linked with reduced joint pain and cognitive side effects of breast cancer therapy

Omega-3 linked with reduced joint pain and cognitive side effects of breast cancer therapy

Osteoporosis drug protects against bone damaging side effects of breast cancer medications

Osteoporosis drug protects against bone damaging side effects of breast cancer medications